Janet Dancey

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

Medicine, Oncology, Treatment Planning +14

Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Frances A. Shepherd, Janet Dancey, Rodryg Ramlau et al. · Journal of Clinical Oncology · 2000 · 2.2K citations

Medicine, Oncology, Pharmacology +16

RECIST 1.1—Update and clarification: From the RECIST committee

Lawrence H. Schwartz, Saskia Litière, Elisabeth G.E. de Vries et al. · European Journal of Cancer · 2016 · 1.9K citations

Agriculture, Public Policy, Separation Of Powers +3

Phase II Trial of Gefitinib in Recurrent Glioblastoma

Jeremy N. Rich, David A. Reardon, Terry Peery et al. · Journal of Clinical Oncology · 2003 · 736 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Evanthia Galanis, Jan C. Buckner, Matthew J. Maurer et al. · Journal of Clinical Oncology · 2005 · 696 citations · Full text

Pharmacy, Oncology, Pharmacology +15